ERS Genomics appoints John E Milad as Chief Executive Officer
ERS Genomics Limited (‘ERS’), the CRISPR licensing company, today announced the appointment of John E Milad as CEO, with immediate effect. John brings over 25 years of experience as an executive leader, venture capitalist, and investment banker focused on the life sciences and medical technology sectors.
https://www.news-medical.net/n....ews/20240513/ERS-Gen
Discover the world at Altruu, The Discovery Engine